This phenomenon was selective for CXCR4 positive breast cancer cells and the viability of both Jurkat and CXCR4 negative MDA-MB-468 cells was not compromised upon exposure to high concentrations of any of the antagonists studied (10 μM). Here, CXCR4 is linked to breast cancer.